Meet-the-Professor Session:
99. Microbiome Therapeutics
Friday, October 5, 2018: 7:15 AM-8:15 AM
Room: S 152-154

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • review the data on the use of fecal microbiota transplants in patients with infectious diseases.
  • discuss the development of novel therapies designed to modify the microbiome to improve human health.

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists

Tracks: Pediatric ID, Trainee, Adult ID


Moderator:  Vincent B. Young, MD, PhD, FIDSA, University of Michigan

Presentations:
7:15 AM
890
Fecal Microbiota Transplants in Infectious Diseases
Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA

CME Credits: Maximum of 1.00 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-217-L01-P

Disclosures:

V. B. Young, Vedanta Biosciences: Consultant , Consulting fee . Finch Therapeutics: Consultant , No financial benefit .

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.